During a symposium beginning Monday at 3:15 p.m. PT in Ballroom 20A-C, Risa Wolf, MD, will share data that suggests GLP-1 receptor agonists can worsen diabetic retinopathy. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
This afternoon: Doc, Is My GLP-1 Med Making My Sight Worse? New Considerations in Management of Diabetic Retinopathy
